Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Armata Pharmaceuticals Inc (ARMP)

3.19   0.21 (7.05%) 10-01 09:10
Open: 3.05 Pre. Close: 2.98
High: 3.215 Low: 3.05
Volume: 1,530 Market Cap: 60M
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company is headquartered in Marina Del Rey, California and currently employs 30 full-time employees. The firm is focused on the discovery, development and commercialization of phage therapeutics. The firm is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The firm is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AB-SA01 and AB-PA01.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.234 - 3.246 3.246 - 3.256
Low: 3.019 - 3.033 3.033 - 3.045
Close: 3.207 - 3.231 3.231 - 3.25

Technical analysis

as of: 2020-09-30 4:38:45 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.00     One year: 4.43
Support: Support1: 2.84    Support2: 2.36
Resistance: Resistance1: 3.43    Resistance2: 3.79
Pivot: 3.30
Moving Average: MA(5): 3.12     MA(20): 3.24
MA(100): 3.56     MA(250): 3.62
MACD: MACD(12,26): -0.06     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 22.85     %D(3): 22.29
RSI: RSI(14): 48.22
52-week: High: 6.92  Low: 2.52  Change(%): -7.7
Average Vol(K): 3-Month: 1597  10-Days: 1005

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ARMP has closed above bottom band by 41.4%. Bollinger Bands are 21.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress - Yahoo Finance

Mon, 28 Sep 2020
Do Analysts Expect Armata Pharmaceuticals Inc (ARMP) Stock to Rise? - InvestorsObserver

Thu, 24 Sep 2020
Financial Insights and Technical Data on Armata Pharmaceuticals Inc. (ARMP) - Invest Million

Thu, 13 Aug 2020
Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update - PRNewswire

Wed, 01 Jul 2020
Is Armata Pharmaceuticals Inc. (ARMP) Going To Reach Wallstreet’s Targets? - Invest Million

Tue, 30 Jun 2020
Here's Why We're Watching Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Situation - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19
Shares Float (M) 7
% Held by Insiders 76.14
% Held by Institutions 7.68
Shares Short (K) 31
Shares Short P. Month (K) 31

Stock Financials

EPS -2.345
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.800
Profit Margin
Operating Margin
Return on Assets (ttm) -43.9
Return on Equity (ttm) -111.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.007
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -1.38
PEG Ratio
Price to Book value 1.79
Price to Sales
Price to Cash Flow -3.47

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.